Search
for
Sort by
Research 151–180 of 1000+
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Alopecia Areata and Alopecia Areata Incognita
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
- Combination of oral minoxidil and bicalutamide for the treatment of female pattern hair loss in adolescents
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review
- Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- CASE REPORT: BIOLOGICAL THERAPY ASSOCIATION, CASE REPORT OF A PATIENT WITH ANKYLOSING SPONDYLITIS AND ALOPECIA AREATA
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Dermatolojik Problemler ve COVID-19
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Application of Baricitinib in Dermatology
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Safety and tolerability of low-dose oral minoxidil in adolescents: A retrospective review
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib